JP2010517990A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010517990A5 JP2010517990A5 JP2009547778A JP2009547778A JP2010517990A5 JP 2010517990 A5 JP2010517990 A5 JP 2010517990A5 JP 2009547778 A JP2009547778 A JP 2009547778A JP 2009547778 A JP2009547778 A JP 2009547778A JP 2010517990 A5 JP2010517990 A5 JP 2010517990A5
- Authority
- JP
- Japan
- Prior art keywords
- condition
- composition
- compound
- composition according
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 3
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 claims 2
- 102000003676 Glucocorticoid Receptors Human genes 0.000 claims 2
- 108090000079 Glucocorticoid Receptors Proteins 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 206010046851 Uveitis Diseases 0.000 claims 1
- 159000000007 calcium salts Chemical class 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 208000024714 major depressive disease Diseases 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88798107P | 2007-02-02 | 2007-02-02 | |
| PCT/IB2008/000229 WO2008093227A1 (en) | 2007-02-02 | 2008-01-25 | Tricyclic compounds and their use as glucocorticoid receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010517990A JP2010517990A (ja) | 2010-05-27 |
| JP2010517990A5 true JP2010517990A5 (https=) | 2010-08-12 |
| JP4599462B2 JP4599462B2 (ja) | 2010-12-15 |
Family
ID=39315208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009547778A Expired - Fee Related JP4599462B2 (ja) | 2007-02-02 | 2008-01-25 | 三環式化合物およびそれらのグルココルチコイド受容体調節剤としての使用 |
Country Status (42)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL189872B1 (pl) | 1996-07-24 | 2005-10-31 | Warner Lambert Co | Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu |
| HRP20110702T1 (hr) * | 2007-02-02 | 2011-10-31 | Pfizer Products Inc. | Triciklički spojevi i njihova uporaba kao modulatora glukokortikoidnih receptora |
| ES2527137T3 (es) | 2008-07-28 | 2015-01-21 | Pfizer Inc. | Compuestos de fenantrenona, composiciones y procedimientos |
| WO2010059894A1 (en) * | 2008-11-21 | 2010-05-27 | Bridge Pharma, Inc. | Ocular formulations of norketotifen |
| US20100135983A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Anti-inflammatory compositions and methods |
| US20100137787A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Delivery devices for modulating inflammation |
| US20100136094A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems for modulating inflammation |
| US20100136096A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems for modulating inflammation |
| US20100137246A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Anti-inflammatory compositions and methods |
| US20100136095A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems for modulating inflammation |
| US20100136097A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems for modulating inflammation |
| AU2011251622A1 (en) | 2010-05-10 | 2012-12-20 | Radikal Therapeutics Inc. | Lipoic acid and nitroxide derivatives and uses thereof |
| KR20130106378A (ko) * | 2010-08-27 | 2013-09-27 | 코어셉트 쎄라퓨틱스, 잉크. | 피리딜-아민 융합된 아자데칼린 조절제 |
| WO2012125797A1 (en) * | 2011-03-15 | 2012-09-20 | Abbott Laboratories | Nuclear hormone receptor modulators |
| US8545904B1 (en) | 2012-06-05 | 2013-10-01 | Liquid Innovators, LLC | Topical composition containing Carapa (andiroba) oil for psoriasis and other related dermatological disorders |
| US9227901B2 (en) | 2012-07-05 | 2016-01-05 | Abbvie Inc. | Process for preparing bicyclic amine derivatives |
| TW201422590A (zh) | 2012-09-07 | 2014-06-16 | Abbvie Inc | 雜環核激素受體調節劑 |
| WO2014094357A1 (en) | 2012-12-21 | 2014-06-26 | Abbvie Inc. | Heterocyclic nuclear hormone receptor modulators |
| MX389718B (es) | 2014-05-16 | 2025-03-20 | Olaplex Inc | Formulaciones y metodos de tratamiento con queratina. |
| EP3848028B9 (en) | 2014-10-20 | 2024-10-16 | Oyster Point Pharma, Inc. | Methods of treating ocular conditions |
| CN104591988A (zh) * | 2014-12-29 | 2015-05-06 | 甘肃省化工研究院 | 6-溴-2-萘满酮的合成方法 |
| WO2016149756A1 (en) | 2015-03-23 | 2016-09-29 | The University Of Melbourne | Treatment of respiratory diseases |
| MX385698B (es) | 2016-04-07 | 2025-03-18 | Oyster Point Pharma Inc | Uso de un compuesto que comprende un grupo pirrolidinilo y pirimidinilo para tratar enfermedades oculares |
| JP7614646B2 (ja) | 2018-11-07 | 2025-01-16 | ティアンリ バイオテック プロプライエタリ リミテッド | 呼吸器疾患の処置のための化合物及び組成物 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2576025B1 (fr) | 1985-01-14 | 1987-01-23 | Roussel Uclaf | Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant |
| FR2600450B1 (fr) * | 1986-06-19 | 1988-08-26 | Pechiney Aluminium | Procede de marquage individuel des anodes precuites pour la production electrolytique d'aluminium |
| GB9518953D0 (en) * | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| IL122740A (en) | 1997-01-15 | 2003-09-17 | Akzo Nobel Nv | 16-hydroxy-11-(substituted phenyl)-estra-9,4-diene derivatives, their preparation and pharmaceutical compositions containing them |
| MXPA01011018A (es) * | 1999-04-30 | 2002-05-06 | Pfizer Prod Inc | Moduladores del receptor glucocorticoide. |
| WO2001005229A1 (en) | 1999-07-15 | 2001-01-25 | The General Hospital Corporation | Non-defective epstein-barr viral vector |
| IL146057A (en) * | 2000-10-27 | 2007-09-20 | Pfizer Prod Inc | A process for the preparation of modulators of a non-steroidal glucocorticoid receptor |
| ES2262612T3 (es) * | 2000-10-28 | 2006-12-01 | Pfizer Products Inc. | Moduladpres del receptor de glucocorticoides. |
| ES2246292T3 (es) | 2000-10-30 | 2006-02-16 | Pfizer Products Inc. | Moduladores de receptor glucocorticoide. |
| US6462661B2 (en) * | 2000-11-20 | 2002-10-08 | Seagate Technology Llc | RF ID tag attachment to a disc drive |
| CA2450748A1 (en) | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions containing polymer and drug assemblies |
| IL160649A0 (en) | 2001-08-31 | 2004-07-25 | Corcept Therapeutics Inc | Methods for inhibiting cognitive deterioration in adults with down syndrome |
| WO2003029217A2 (en) | 2001-09-27 | 2003-04-10 | Universite De Liege | Pyridinic sulfonamide derivatives, method of production and use thereof |
| DE10164366C1 (de) * | 2001-12-28 | 2003-06-05 | Rehau Ag & Co | Permanentkathode |
| DE60320940D1 (de) | 2002-02-01 | 2008-06-26 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien |
| CN1665515A (zh) | 2002-07-02 | 2005-09-07 | 科塞普特治疗公司 | 治疗与干扰素α治疗相关的精神病的方法 |
| JP4503436B2 (ja) | 2002-07-08 | 2010-07-14 | ファイザー・プロダクツ・インク | 糖質コルチコイド受容体のモジュレーター |
| JP2006508951A (ja) | 2002-11-05 | 2006-03-16 | コーセプト セラピューティクス， インコーポレイテッド | 片頭痛を処置するための方法 |
| EP1599208A4 (en) | 2003-02-04 | 2007-09-12 | Corcept Therapeutics Inc | ANTIGLUCOCORTICOIDES FOR THE TREATMENT OF POSTPARTAL PSYCHOSIS |
| US20050080061A1 (en) | 2003-07-23 | 2005-04-14 | Corcept Therapeutics, Inc. | Antiglucocorticoid therapy for the prevention of neurological damage in premature infants |
| US8097606B2 (en) | 2003-07-23 | 2012-01-17 | Corcept Therapeutics, Inc. | Antiglucocorticoids for the treatment of catatonia |
| TW200512181A (en) | 2003-09-26 | 2005-04-01 | Tanabe Seiyaku Co | Amide-type carboxamide derivatives |
| WO2005047524A2 (en) * | 2003-11-10 | 2005-05-26 | The Scripps Research Institute | Compositions and methods for inducing cell dedifferentiation |
| CA2545020A1 (en) * | 2003-11-13 | 2005-05-26 | Pfizer Products Inc. | Octahydrophenanthrene hydrazinde derivatives useful as glucocorticoid receptor modulators |
| TWI370129B (en) | 2005-02-14 | 2012-08-11 | Msd Oss Bv | Non steroidal glucocorticoid receptor modulators |
| JP2009535430A (ja) | 2006-05-02 | 2009-10-01 | コーセプト セラピューティクス， インコーポレイテッド | Ｉｌ−２を摂取している患者における抑うつを処置するためのグルココルチコイドレセプターｉｉアンタゴニストの使用 |
| EP2114888B1 (en) * | 2007-02-02 | 2010-11-10 | Pfizer Products Inc. | Tricyclic compounds and their use as glucocorticoid receptor modulators |
| HRP20110702T1 (hr) * | 2007-02-02 | 2011-10-31 | Pfizer Products Inc. | Triciklički spojevi i njihova uporaba kao modulatora glukokortikoidnih receptora |
-
2008
- 2008-01-25 HR HR20110702T patent/HRP20110702T1/hr unknown
- 2008-01-25 DK DK08702351.1T patent/DK2114970T3/da active
- 2008-01-25 EP EP08702351A patent/EP2114970B1/en active Active
- 2008-01-25 MY MYPI20123293 patent/MY153057A/en unknown
- 2008-01-25 KR KR1020097018289A patent/KR101107949B1/ko not_active Expired - Fee Related
- 2008-01-25 WO PCT/IB2008/000229 patent/WO2008093227A1/en not_active Ceased
- 2008-01-25 AU AU2008211613A patent/AU2008211613B2/en not_active Ceased
- 2008-01-25 AT AT08702351T patent/ATE518872T1/de active
- 2008-01-25 EA EA200970666A patent/EA016494B1/ru not_active IP Right Cessation
- 2008-01-25 JP JP2009547778A patent/JP4599462B2/ja not_active Expired - Fee Related
- 2008-01-25 MX MX2009008284A patent/MX2009008284A/es active IP Right Grant
- 2008-01-25 PL PL08702351T patent/PL2114970T3/pl unknown
- 2008-01-25 NZ NZ578638A patent/NZ578638A/en not_active IP Right Cessation
- 2008-01-25 SI SI200830393T patent/SI2114970T1/sl unknown
- 2008-01-25 AP AP2009004942A patent/AP2455A/xx active
- 2008-01-25 UA UAA200907728A patent/UA94639C2/ru unknown
- 2008-01-25 ES ES08702351T patent/ES2368286T3/es active Active
- 2008-01-25 GE GEAP200811399A patent/GEP20125404B/en unknown
- 2008-01-25 MY MYPI20093089A patent/MY146087A/en unknown
- 2008-01-25 CN CN2008800052954A patent/CN101616925B/zh not_active Expired - Fee Related
- 2008-01-25 PT PT08702351T patent/PT2114970E/pt unknown
- 2008-01-25 RS RS20110429A patent/RS51970B/sr unknown
- 2008-01-25 BR BRPI0808634-6A patent/BRPI0808634A2/pt not_active IP Right Cessation
- 2008-01-25 CA CA2676670A patent/CA2676670C/en not_active Expired - Fee Related
- 2008-01-28 UA UAA200907730A patent/UA95332C2/uk unknown
- 2008-01-28 CN CN2008800056527A patent/CN101616896B/zh not_active Expired - Fee Related
- 2008-01-28 RS RS20110008A patent/RS51646B/sr unknown
- 2008-01-28 KR KR1020097018294A patent/KR101114682B1/ko not_active Expired - Fee Related
- 2008-01-28 MY MYPI20093135A patent/MY148780A/en unknown
- 2008-01-28 GE GEAP200811398A patent/GEP20125426B/en unknown
- 2008-01-28 PT PT08702358T patent/PT2114888E/pt unknown
- 2008-01-28 ES ES08702358T patent/ES2353822T3/es active Active
- 2008-01-31 US US12/023,323 patent/US7547714B2/en not_active Expired - Fee Related
- 2008-01-31 US US12/023,362 patent/US7598231B2/en not_active Expired - Fee Related
- 2008-01-31 PE PE2008000231A patent/PE20081736A1/es not_active Application Discontinuation
- 2008-02-01 AR ARP080100425A patent/AR065135A1/es active IP Right Grant
- 2008-02-01 HN HN2008000178A patent/HN2008000178A/es unknown
- 2008-02-01 TW TW097104089A patent/TWI347842B/zh active
- 2008-02-01 CL CL200800330A patent/CL2008000330A1/es unknown
- 2008-02-01 HN HN2008000179A patent/HN2008000179A/es unknown
- 2008-02-01 AR ARP080100424A patent/AR065134A1/es active IP Right Grant
- 2008-02-01 PE PE2008000234A patent/PE20090113A1/es not_active Application Discontinuation
- 2008-02-01 CL CL200800329A patent/CL2008000329A1/es unknown
- 2008-02-01 TW TW097104074A patent/TWI373466B/zh not_active IP Right Cessation
-
2009
- 2009-05-08 US US12/437,704 patent/US8158660B2/en not_active Expired - Fee Related
- 2009-07-20 IL IL199972A patent/IL199972A/en active IP Right Grant
- 2009-07-21 US US12/506,825 patent/US7786097B2/en not_active Expired - Fee Related
- 2009-07-23 CR CR10948A patent/CR10948A/es not_active IP Right Cessation
- 2009-07-23 CR CR10949A patent/CR10949A/es not_active IP Right Cessation
- 2009-07-24 CU CU20090133A patent/CU23824A3/es active IP Right Grant
- 2009-07-24 CU CU2009000132A patent/CU23848B1/es active IP Right Grant
- 2009-07-29 DO DO2009000190A patent/DOP2009000190A/es unknown
- 2009-07-29 NI NI200900149A patent/NI200900149A/es unknown
- 2009-07-29 NI NI200900148A patent/NI200900148A/es unknown
- 2009-07-30 GT GT200900210A patent/GT200900210A/es unknown
- 2009-07-30 GT GT200900209A patent/GT200900209A/es unknown
- 2009-07-30 SV SV2009003346A patent/SV2009003346A/es not_active Application Discontinuation
- 2009-07-31 MA MA32128A patent/MA31158B1/fr unknown
- 2009-07-31 TN TNP2009000324A patent/TN2009000324A1/fr unknown
- 2009-07-31 CO CO09079796A patent/CO6190603A2/es active IP Right Grant
- 2009-07-31 MA MA32127A patent/MA31117B1/fr unknown
- 2009-07-31 CO CO09079789A patent/CO6220937A2/es active IP Right Grant
- 2009-07-31 EC EC2009009553A patent/ECSP099553A/es unknown
- 2009-07-31 EC EC2009009552A patent/ECSP099552A/es unknown
- 2009-07-31 SV SV2009003349A patent/SV2009003349A/es active IP Right Grant
- 2009-09-01 ZA ZA200906064A patent/ZA200906064B/xx unknown
- 2009-09-01 ZA ZA200906060A patent/ZA200906060B/xx unknown
-
2010
- 2010-12-02 CY CY20101101109T patent/CY1110962T1/el unknown
-
2011
- 2011-08-17 CY CY20111100784T patent/CY1111758T1/el unknown
- 2011-12-21 US US13/333,104 patent/US8445520B2/en not_active Expired - Fee Related
-
2013
- 2013-04-16 US US13/863,534 patent/US20140142316A1/en not_active Abandoned
-
2014
- 2014-07-01 US US14/320,674 patent/US8901310B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010517990A5 (https=) | ||
| JP2010533203A5 (https=) | ||
| CA2676670A1 (en) | Tricyclic compounds, compositions, and methods | |
| JP2010536766A5 (https=) | ||
| JP2010517991A5 (https=) | ||
| JP2007535611A5 (https=) | ||
| JP2009535462A5 (https=) | ||
| JP2014029971A5 (ja) | 有機化合物 | |
| JP2011513196A5 (https=) | ||
| JP2010534247A5 (https=) | ||
| JP2012092103A5 (https=) | ||
| JP2010501534A5 (https=) | ||
| JP2010141309A5 (ja) | 発光素子 | |
| JP2009149903A5 (https=) | ||
| JP2007537295A5 (https=) | ||
| JP2011500769A5 (https=) | ||
| JP2014514960A5 (https=) | ||
| JP2010530897A5 (https=) | ||
| JP2010530373A5 (https=) | ||
| JP2014515008A5 (https=) | ||
| JP2010516852A5 (https=) | ||
| CA2676907A1 (en) | Tricyclic compounds and their use as glucocorticoid receptor modulators | |
| JP2014097964A5 (https=) | ||
| JP2014028784A5 (ja) | 複素環化合物および有機化合物 | |
| JP2011519825A5 (https=) |